The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Axcella Health Inc | COM | 05454B204 | 7,576,142 | 725,684 | SH | DFND | 2,3 | 0 | 725,684 | 0 | ||
| Axcella Health Inc | COM | 05454B204 | 4,639,275 | 444,375 | SH | DFND | 3 | 0 | 444,375 | 0 | ||
| Denali Therapeutics Inc | COM | 24823R105 | 54,049,940 | 2,619,968 | SH | DFND | 1,3 | 0 | 2,619,968 | 0 | ||
| Evelo Biosciences Inc | COM | 299734202 | 6,234,308 | 1,590,385 | SH | DFND | 2,3 | 0 | 1,590,385 | 0 | ||
| Evelo Biosciences Inc | COM | 299734202 | 2,000,238 | 510,265 | SH | DFND | 1,3 | 0 | 510,265 | 0 | ||
| Evelo Biosciences Inc | COM | 299734202 | 22,861,338 | 5,831,974 | SH | DFND | 3 | 0 | 5,831,974 | 0 | ||
| Foghorn Therapeutics Inc | COM | 344174107 | 46,654,390 | 9,330,878 | SH | DFND | 1,3 | 0 | 9,330,878 | 0 | ||
| Foghorn Therapeutics Inc | COM | 344174107 | 16,716,210 | 3,343,242 | SH | DFND | 3 | 0 | 3,343,242 | 0 | ||
| Moderna Inc | COM | 60770K107 | 997,999,755 | 9,662,114 | SH | DFND | 2,3 | 0 | 9,662,114 | 0 | ||
| Moderna Inc | COM | 60770K107 | 405,310 | 3,924 | SH | DFND | 3 | 0 | 3,924 | 0 | ||
| Omega Therapeutics Inc | COM | 68217N105 | 15,017,441 | 6,984,856 | SH | DFND | 1,3 | 0 | 6,984,856 | 0 | ||
| Omega Therapeutics Inc | COM | 68217N105 | 47,817,555 | 22,240,723 | SH | DFND | 3 | 0 | 22,240,723 | 0 | ||
| Sana Biotechnology Inc | COM | 799566104 | 35,188,664 | 9,092,678 | SH | DFND | 1,3 | 0 | 9,092,678 | 0 | ||
| Sana Biotechnology Inc | COM | 799566104 | 61,568,519 | 15,909,178 | SH | DFND | 3 | 0 | 15,909,178 | 0 | ||
| Seres Therapeutics Inc | COM | 81750R102 | 20,117,845 | 8,452,876 | SH | DFND | 2,3 | 0 | 8,452,876 | 0 | ||
| Seres Therapeutics Inc | COM | 81750R102 | 34,900,722 | 14,664,169 | SH | DFND | 3 | 0 | 14,664,169 | 0 | ||
| Syros Pharmaceuticals Inc | COM | 87184Q206 | 1,160,700 | 293,848 | SH | DFND | 2,3 | 0 | 293,848 | 0 | ||
| Syros Pharmaceuticals Inc | COM | 87184Q206 | 2,765,000 | 700,000 | SH | DFND | 3 | 0 | 700,000 | 0 | ||